NCT04750083 2021-02-11HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung CancerTaizhou Hanzhong biomedical co. LTDPhase 2/3 Unknown700 enrolled